NCT01708161
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01708161 |
| Title | A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Novartis|Novartis Pharmaceuticals|Amgen |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ESP | CAN | BEL |
CKB BOOST